VLPDVFIRCV
VLPDVFIRCV, a melanoma antigen-derived peptide, is the intron sequence (nt 38-67) of the N-acetylglucosamine transferase V (GnT-V) gene. VLPDVFIRCV has a high affinity for MHC-I class molecules, but it cannot activate the immune response against natural tumor cells. The cytotoxic T lymphocytes (CTL) induced by VLPDVFIRCV can specifically lyse T2 cells loaded with this peptide in the chromium release experiment. VLPDVFIRCV can be used for vaccine design research[1].
Product Specifications
CAS Number
[176510-49-9]
UNSPSC
12352209
Target
MHC
Related Pathways
Immunology/Inflammation
Field of Research
Cancer
Smiles
Molecular Formula
C54H89N13O13S
Molecular Weight
1160.43
References & Citations
[1]Nolte A, et al. Generation of melanoma-specific cytotoxic T lymphocytes for allogeneic immunotherapy. J Immunother. 2003 May-Jun;26 (3) :257-69.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
CD4 (CD4 Receptor, CD4mut, T Cell Surface Antigen T4/Leu3, T Cell Surface Glycoprotein CD4 (MaxLight 405)
CD4 (CD4 Receptor, CD4mut, T Cell Surface Antigen T4/Leu3, T Cell Surface Glycoprotein CD4 (MaxLight 405)
